Skip to main content

Treatment Decisions Without Diagnostic Tests

  • Chapter
  • First Online:
Medical Decision Making
  • 1145 Accesses

Abstract

We consider a medical case which requires a physician’s treatment decision where no diagnostic test is available. The physician knows the particular illness and its treatment, as well as a sick person’s utility gain and a healthy person’s utility loss from treatment. But he is uncertain whether the patient is actually sick or not. To aid his decision, we derive a lower boundary for the a priori probability of the illness at which treatment is indicated. We show that a risk-averse physician should treat at a lower a priori probability than a risk-neutral physician. We also analyze the therapeutic risk, i.e., the risk that treatment fails, and derive the success probability threshold, above which the physician will undertake treatment. In contrast to the diagnostic risk, the threshold for the successful treatment probability is higher for a risk-averse decision maker than for a risk-neutral one. Finally, we consider the diagnostic risk and the therapeutic risk simultaneously and study the thresholds in this extended model.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    ‘By virtue of theory and experience, I have the right to suspect the first who comes along to be a carrier of germs.’—Romains, J.—Knock ou le triomphe de la medicine—Gallimard, Paris—1923, p. 74.

  2. 2.

    Situations arise, however, where the harm to the healthy is greater than the gain for the sick. One example is serum used to treat snake bites. Treatment may help a sick individual to survive, while it could be deadly if given to a healthy individual.

  3. 3.

    In Fig. 4.4, the difference in expected utility from treatment between risk-averse and risk-neutral decision makers increases with increasing p. This holds only if \( {g}_A-{g}_N>{l}_N-{l}_A \).

  4. 4.

    Note that the negative slope of the \( E{U}_i^{-}(p) \) line—see Eq. (4.4)—is in fact the decisive factor for the result. Even if the \( E{U}_i^{+}(p) \) line had a negative slope the treatment threshold would still be lower for a risk-averse decision maker than for a risk-neutral one.

References

  • Eeckhoudt, L. (2002). Risk and medical decision making. Boston: Kluwer.

    Book  Google Scholar 

  • Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic decision making: A cost benefit analysis. New England Journal of Medicine, 293(5), 229–234.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Exercises

Exercises

  1. 1.

    This exercise is adopted from Eeckhoudt (2002), p. 21. After a physician has thoroughly examined a patient, he must decide for or against treatment. Assume that the patient’s utility can be measured in QALYs. If the patient is sick and does not undergo treatment, he obtains 10 QALYs. If the sick patient is treated, his utility increases by 15 QALYs. There is, however, a chance that the patient does not actually suffer from the particular illness. In this case, he obtains 50 QALYs if he is not treated. If the physician treats the patient despite his good health, a utility loss of 5 QALYs will ensue.

    1. (a)

      How large are g and l in this situation?

    2. (b)

      Calculate the treatment threshold.

    3. (c)

      Imagine that this is not a single case, but that a physician’s practice features 100 patients from one population group with an a priori disease prevalence rate of 0.1, 200 patients from another group with a prevalence rate of 0.2, and 50 patients from a third group with an a priori rate of 0.6.

      1. (1)

        How many patients will receive treatment if the physician follows the threshold rule?

      2. (2)

        How large is the expected number of QALYs in the entire patient population if

        • No patient gets treatment?

        • All patients get treatment?

        • The physician follows the threshold rule?

    4. (d)

      Assume that the effectiveness of treatment increases such that a sick patient undergoing treatment obtains 28 QALYs and a healthy patient obtains 47 QALYs after treatment.

      1. (1)

        How does this affect the treatment threshold?

      2. (2)

        How many patients are treated now?

      3. (3)

        Calculate the new number of QALYs if

        • No patient gets treatment.

        • All patients get treatment.

        • The physician follows the threshold rule.

    5. (e)

      Draw the equivalent of Fig. 4.2 for the situations before and after the improved treatment.

  2. 2.

    Show that even if the \( E{U}_i^{+}(p) \) line has a negative slope, the treatment threshold is lower for a risk-averse decision maker than for a risk-neutral one.

  3. 3.

    The following values are given for these health states: \( {h}_s^{+s}=36; \) \( {h}_s^{-}=25; \) \( {h}_s^{+f}=16 \). A risk-neutral decision maker has the utility function \( u(h)=0.1\cdot h+2.4 \). The utility function of the risk-averse decision maker is \( u(h)=\sqrt{h}. \)

    1. (a)

      Calculate the utility gains from successful treatment and the utility loss from a failure for both types of decision maker.

    2. (b)

      At which success probability will the risk-neutral physician start to treat? What is the threshold for the risk-averse physician?

    3. (c)

      Draw Fig. 4.9 for the above values.

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Germany

About this chapter

Cite this chapter

Felder, S., Mayrhofer, T. (2017). Treatment Decisions Without Diagnostic Tests. In: Medical Decision Making. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53432-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53432-8_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53431-1

  • Online ISBN: 978-3-662-53432-8

  • eBook Packages: Economics and FinanceEconomics and Finance (R0)

Publish with us

Policies and ethics